News & Events

Investors, Press Releases

The Board of Directors approves the net financial position for the first quarter of 2021

May 12, 2021

The Board of Directors approves the net financial position for the first quarter of 2021 in the amount of 104,668 thousand euro, and acknowledges the progress of the main clinical trials on Nidlegy™ and Fibromun in line with the expected timelines (Price Sensitive)

Last News & Events

Oct 2021 20

Comunicato relativo all’approvazione del CdA sulla proposta di autorizzazione all’acquisto e alla disposizione di azioni proprie (Price Sensitive)

Oct 2021 15

Philogen to Participate at the 2021 Virtual Stifel Healthcare Conference on November 15-17, 2021

1
2
3
…
31
Next »